Examining the trough plasma levels of Amikacin is essential for evaluating the drug’s potential toxicity. Amikacin is commonly administered for severe gram-negative infections. However, its usage can lead to side effects such as ototoxicity and nephrotoxicity. Healthcare professionals employ this test to gauge the drug’s toxicity levels and establish appropriate dosing regimens, particularly for prolonged treatment courses.